Literature DB >> 8436159

Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.

J Mehlsen1, C Stadeager, J Trap-Jensen.   

Abstract

The central haemodynamic effects of pindolol and xamoterol have been investigated in patients with postural hypotension. Pindolol is a non-selective beta-adrenoceptor partial agonist, whereas xamoterol is beta 1-selective and possesses a higher degree of agonist activity. The study comprised 16 patients with postural hypotension of different aetiologies. Blood pressure, heart rate and stroke volume were measured in the supine and head-up tilted positions. Left ventricular ejection fraction (LVEF) was measured in the supine position, and vascular resistance, left ventricular volume, and left ventricular contractility were derived. Pindolol and xamoterol were administered intravenously in incremental doses to reach total doses of 0.02 and 0.20 mg.kg-1, respectively. Pindolol showed beta-adrenoceptor antagonistic effects in the supine position through decrements in heart rate from 70 to 66 beats.min-1 and LVEF from 0.57 to 0.52, and reduced mean arterial blood pressure from 103 mm Hg to 93 mm Hg. Xamoterol showed beta-adrenoceptor agonistic effects in the supine position through increments in heart rate from 72 to 90 beats.min-1 and LVEF from 0.58 to 0.66, and raised mean arterial blood pressure from 108 to 123 mm Hg. It is concluded that the degree of agonist activity of a beta-adrenergic agent is of importance if it is given to a patient with postural hypotension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436159     DOI: 10.1007/bf00315272

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study.

Authors:  G M SHY; G A DRAGER
Journal:  Arch Neurol       Date:  1960-05

2.  Reduced plasma norepinephrine response to standing in autonomic dysfunction.

Authors:  P E Cryer; S Weiss
Journal:  Arch Neurol       Date:  1976-04

3.  Treatment of idiopathic orthostatic hypotension with xamoterol.

Authors:  H Yamashita; O Yahara; N Hasebe; Y Kawamura; A Obara; H Honda; T Kimura; S Onodera
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

4.  Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.

Authors:  M Tangø; J E Carlsen; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Beta-receptors in orthostatic hypotension.

Authors: 
Journal:  N Engl J Med       Date:  1981-10-22       Impact factor: 91.245

6.  Pindolol in orthostatic hypotension: possible therapy?

Authors:  D B Frewin; P P Leonello; R K Penhall; L Hughes; P E Harding
Journal:  Med J Aust       Date:  1980-02-09       Impact factor: 7.738

7.  Effects of xamoterol (ICI 118,587) in asthmatic patients.

Authors:  C G Löfdahl; N Svedmyr
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

8.  Central haemodynamics in patients with severe postural hypotension.

Authors:  J Mehlsen; C Haedersdal; J Trap-Jensen
Journal:  Clin Physiol       Date:  1991-11

9.  Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations.

Authors:  W Grossman; E Braunwald; T Mann; L P McLaurin; L H Green
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

10.  Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.

Authors:  J Mehlsen; J Trap-Jensen
Journal:  Acta Med Scand       Date:  1986
View more
  2 in total

Review 1.  Age-related decline in autonomic control of blood pressure: implications for the pharmacological management of hypertension in the elderly.

Authors:  Ton J Cleophas; Rob van Marum
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

2.  A clinical, physiology and pharmacology evaluation of orthostatic hypotension in the elderly.

Authors:  Manish Sahni; David T Lowenthal; John Meuleman
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.266

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.